In the BioHarmony Drug Report Database

"Preview" Icon

Milnacipran

Savella (milnacipran) is a small molecule pharmaceutical. Milnacipran was first approved as Savella on 2009-01-14. It is used to treat major depressive disorder in the USA. The pharmaceutical is active against sodium-dependent serotonin transporter and sodium-dependent noradrenaline transporter. Savella’s patents are valid until 2029-09-19 (FDA).

 

Trade Name

 

Savella
 

Common Name

 

milnacipran
 

ChEMBL ID

 

CHEMBL259209
 

Indication

 

major depressive disorder
 

Drug Class

 

Image (chem structure or protein)

Milnacipran structure rendering